Research Focus

Clinical Pipeline

Melanocortin Receptor Programs Pre-Clinical Phase 1 Phase 2 Phase 3 NDA Submission FDA Approval

Rekynda (bremelanotide) MC4r Agonist

Hypoactive Sexual Desire Disorder

PL-8177 MC1r Agonist

Inflammatory Bowel Disease

MC1/5r Agonist

Anti-inflammatory Ocular Indications

MC4r Agonist

Obesity, Metabolic Syndrome and Diseases

Natriuretic Peptide Receptor Programs Pre-Clinical Phase 1 Phase 2 Phase 3 NDA Submission FDA Approval

PL-3994 NPR-A

Heart Failure

NPR-A/C Agonist

Heart Failure and Fibrosis